Roopa Industries Limited (BOM:530991)

Market Cap	344.98M -21.0%
Revenue (ttm)	1.26B +1.8%
Net Income	1.28M -93.7%
EPS	0.20 -92.2%
Shares Out	7.87M
PE Ratio	216.85
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9
Open	47.79
Previous Close	45.85
Day's Range	43.85 - 47.79
52-Week Range	38.10 - 63.40
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Roopa Industries

Roopa Industries Limited manufactures, markets, and sells bulk drugs, intermediaries, and fine chemicals in India and internationally. The company offers triphenylphosphine, abacavir sulphate, d-penicillamine, s-octabase, DCC, and DPA 3, etc. It also manufactures and exports glucosamine salts. It serves pharma industry. Roopa Industries Limited was incorporated in 1985 and is based in Hyderabad, India.

• Industry: Chemicals and Allied Products
• Founded: 1985
• Employees: 56
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530991

Financial Performance

In fiscal year 2026, Roopa Industries's revenue was 1.28 billion, an increase of 5.30% compared to the previous year's 1.21 billion. Earnings were 831,000, a decrease of -95.92%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error